Europe Is Not a Rescue Plan ft. Jamie Pearson
Global expansion is often pitched as an opportunity. For an undisciplined cannabis company, it is an expensive way to expose every weakness at once.International markets reward specific operating capabilities, not ambiti...
Full Show Notes
Global expansion is often pitched as an opportunity. For an undisciplined cannabis company, it is an expensive way to expose every weakness at once.
International markets reward specific operating capabilities, not ambition alone. Pharmaceutical standards, reliable supply, disciplined data use, and local market fit determine whether an operator can cross borders without compounding its problems.
This week we sit down with Jamie Pearson
- EU GMP's undervalued strategic value
- Regulation exposes operating weakness
- Matching strength to global markets
On The Dime, host Bryan Fields speaks with Jamie L. Pearson, President and Founder of New Holland Group, about European cannabis expansion, medical cannabis supply chains, and building operations that can succeed across borders.
Key Takeaways
- Jamie explains why European medical cannabis markets call for pharmaceutical reliability, consistent supply, and a different operating model from adult-use brands.
- EU GMP (European Union Good Manufacturing Practice) capability can be a strategic asset for cannabis manufacturing and international market entry.
- Match the company's repeatable strengths to local buyers, regulations, and supply chains before choosing a market.
- Prove standard operating procedures (SOPs) and quality controls in another U.S. state before adding language, currency, and cross-border complexity.
- The discussion spans the UK, Germany, Switzerland, Slovenia, Portugal, and Brazil, alongside cannabis data and U.S. hemp regulation.
Chapters
00:00 Regulation is breaking the data layer
02:49 Finding trend data upstream
06:24 What EU GMP actually demands
10:19 Why compliant facilities become strategic assets
16:13 Canada-Europe regulatory harmony
19:20 Europe is medical first
25:28 First-mover advantage vs. disciplined execution
27:59 Medical supply rewards repeatability
30:48 Weak operations do not travel
32:24 Switzerland, Slovenia, and Portugal
35:54 Brazil and partner requirements
37:07 Practice expansion before global scale
40:08 The hidden U.S. hemp market
43:29 Turning customers into political force
47:10 Directness as respect
Guest Links
Related Episode
Germany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka — continue exploring Germany's cannabis market and operational discipline.
Our Links
- The Dime Podcast — website
- Bryan Fields on X
- The Dime on X
- The Dime on YouTube
- The Dime on Instagram
- Eighth Revolution
- Newton Insights — insights for extraction teams
Follow The Dime for more conversations on cannabis business, operations, and international markets. Share this episode with an operator considering expansion.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.